Table 1.
Overall patient demographics
| Characteristics | Patients (N=2,536) |
|---|---|
| Age, years, mean (SD)a | 52.76 (14.32) |
| Female, n (%) | 1,808 (71) |
| BMI, kg/m2, mean (SD)b | 25.22 (4.29) |
| Time since RA diagnosis, years, mean (SD)c | 6.05 (6.81) |
| Disease severity at the initiation of current treatment, n (%) | |
| Mild | 345 (14) |
| Moderate | 1,417 (56) |
| Severe | 774 (31) |
| Prior bDMARD therapy, n (%) | |
| Yes | 926 (37) |
| No | 1,610 (63) |
| Currently still receiving bDMARD therapyd | 859 (93) |
Notes:
a
Data missing from eleven patients.
b
Data missing from two patients.
c
Data missing from 155 patients.
d
Data are a subset of the 926 patients in the ‘Yes’ category of this variable.
Abbreviations: bDMARD, biologic disease-modifying antirheumatic drug; BMI, body mass index; RA, rheumatoid arthritis.